|
TABLE 1: Adverse Ocular Effects of Some Common Medications |
|
Category |
Class |
Examples |
Adverse Ocular Effect(s) |
|
Allergy
|
Antihistamines
|
Nonselective H1-receptor Inhibitors:
- Benadryl® (diphenhydramine)
- Chlor-Trimeton® (chlorpheniramine)
|
- Pupillary changes
- Decreased vision
- Dry eye
|
|
Selective H1-receptor Inhibitors:
- Claritin® (loratadine)
- Zyrtec® (cetirizine)
|
- Lacrimation
- Dry eye
- Contact lens discomfort
|
|
Corticosteroids |
|
- Cataract
- Elevated intraocular pressure
- Photophobia
- Mydriasis
- Decreased vision
|
|
Cardiovascular agents |
Angiotensin converting enzyme inhibitors |
- Capoten® (captopril)
- Vasotec® (enalapril)
|
- Decreased vision
- Conjunctivitis
- Blepharoconjunctivitis
- Photosensitivity
- Angioedema of the eye and orbit
|
|
Antiarrhythmics |
|
- Photosensitivity
- Photophobia
- Keratopathy
- Optic neuropathy
|
|
Beta-receptor blockers |
- Tenormin® (atenolol)
- Lopressor® (metoprolol)
- Inderal® (propranolol)
- Coreg® (carvedilol)
- Norvasc® (amlodipine)
|
- Reduced tear secretion
- Visual disturbances
- Erythema of the eyelids or conjunctiva
- Photophobia
- Nonspecific conjunctivitis
- Diplopia
- Urticaria
|
|
Calcium channel blockers |
- Adalat®, Procardia® (nifedipine)
- Calan® (verapamil)
|
- Photosensitivity
- Decreased vision
- Periorbital edema
- Chemosis
|
|
Digitalis glycosides |
- Lanoxin® (digoxin)
- Digitoxin
|
- Changes in color vision
- Entopic phenomena
- Sensitivity to glare
|
|
Diuretics |
- HydroDIURIL® (hydrochlorothiazide)
- Lasix® (furosemide)
|
- Photosensitivity
- Myopia
- Reduced tear production
- Changes in color vision
|
|
Central nervous system agents |
Antianxiety agents |
- Xanax® (alprazolam)
- Ativan® (lorazepam)
- Valium® (diazepam)
|
- Diplopia
- Abnormal extra-ocular muscle movements
- Decreases in corneal reflex
- Conjunctivitis
|
|
Antidepressants |
Selective serotonin reuptake inhibitors:
|
|
|
Tricyclic antidepressants:
|
- Mydriasis
- Cycloplegia
- Dry eyes
- Photophobia
- Photosensitivity
|
|
Central nervous system stimulants |
Amphetamines:
- Dexedrine®
- Ritalin® (methylphenidate)
- Methamphetamine
|
- Mydriasis
- Decreased pupil reaction to light
|
|
Antipsychotic agents |
- Thorazine® (chlorpromazine)
- Mellaril® (thioridazine)
|
- Mydriasis
- Increased incidence of cataract
- Corneal endothelial pigmentary changes
|
|
Anticonvulsants |
- Neurontin® (gabapentin)
- Lamictal® (lamotrigine)
- Topamax® (topiramate)
|
- Diplopia
- Blurred vision
- Nystagmus
|
|
Hydantoins:
|
- External ophthalmoplegia
- Diplopia
- Nystagmus
|
|
Dermatologic agents |
Retinoids |
|
- Reduced vision
- Keratitis
- Corneal opacities
- Blepharoconjunctivitis
- Conjunctivitis
- Optic neuritis
- Dry eyes
- Photosensitivity
- Night blindness (permanent)
|
|
HIV/AIDS related agents |
|
|
- Hypotony
- Retinal detachment
- Increased intra-ocular pressure
- Cataract (ganciclovir implants)
|
- Retrovir® (zidovudine)
- Combivir® (lamivudine/zidovudine)
|
- Cystoid macular edema
- Hypertrichosis
- Hyperpigmentation of the eyelids and conjunctiva
|
|
|
- Retinal toxicity, mottling of the retinal pigment
- epithelium and atrophy in the mid-periphery of the fundi
- Optic neuritis
- Night blindness
|
|
Neoplastic agents
|
Antiestrogen |
|
- Vision loss
- Retinal edema
- Retinal hemorrhage
- Optic disc swelling
- Cystoid macular edema
- Retinal pigment epithelial changes
|
|
Alkylating agents |
|
- Posterior subcapsular cataract
- Keratoconjunctivitis sicca
- Loss of eyelashes or eyebrows
|
|
|
- Secondary glaucoma
- Internal ophthalmoplegia
- Optic neuritis
|
|
|
- Ipsilateral vision loss
- Blurred vision
- Color deficiency
- Disc edema
|
|
Antimetabolite |
|
- Blepharitis
- Conjunctival irritation
- Cicatricial reaction in conjunctiva, punctum, canaliculus, and lacrimal sac that can result in irreversible scarring
|
|
Folic acid antagonists |
|
- Blepharitis
- Periorbital edema
- Conjunctival hyperemia
- Increased lacrimation
- Photophobia
|
|
Antibiotic antineoplastic agents |
- Blenoxane® (bleomycin)
- Adriamycin PFS/RDF (doxorubicin)
|
- Conjunctivitis
- Lacrimation
- Blurred vision
|
|
|
- Corneal and scleral melts
- Permanent porcelainization of the conjunctiva and sclera
|
|
Hormones and agents affecting hormonal mechanisms |
Bisphosphonates |
- Fosamax® (alendronate)
- Didronel® (etidronate)
- Aredia® (pamidronate)
- Actonel® (risedronate)
|
- Uveitis
- Nonspecific conjunctivitis
- Ocular pain
- Blurred vision
- Scleritis
|
|
Erectile dysfunction agents |
- Viagra® (sildenafil)
- Levitra® (vardenafil)
- Cialis® (tadalafil)
|
- Color vision effects
- Increased light sensitivity
- Blurred vision
- Conjunctival hyperemia
- Ocular pain
|
|
Analgesic agents |
Nonsteroidal anti-inflammatory drugs |
|
- Transient blurred vision
- Refractive error changes
- Diplopia
- Photophobia
- Dry eyes
- Color vision problems
|
|
Anticholinergics |
|
- Mydriasis
- Absence of reaction to light
|
- Transderm Scop® (scopolamine)
|
|
|
Antimicrobial agents |
Fluoroquinolones |
- Ciprofloxacin
- Norfloxacin
- Ofloxacin
|
- Glare phenomenon
- Photophobia
- Photosensitivity
|
|
Herbal products and nutritional Supplements |
|
- Henbane (Hyoscyamus niger)
- Kava kava (Piper methysticum)
|
|
- Chamomile (Matricaria chamomilla)
- Propolis
|
|
|
|
|
- Bitter orange (Citrus aurantium)
|
|
- Henbane (Hyoscyamus niger)
- Ginkgo (Ginkgo biloba)
|
- Hyphema
- Retinal hemorrhage
|
- Mandrake (Mandragora officinarum)
- Valerian (Valeriana officinalis)
|
|
- St. John’s wort (Hypericum perforatum)
|
|